We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
story of the week
Published in Respiratory Medicine and
2 other channels

Journal Scan / Research · December 16, 2020

High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine in Patients With High-Risk CVD

JAMA: The Journal of the American Medical Association

 

Save Recommend
Share

Additional Info

JAMA: The Journal of the American Medical Association
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-Risk Cardiovascular Disease: A Randomized Clinical Trial
JAMA 2020 Dec 04;[EPub Ahead of Print], O Vardeny, K Kim, JA Udell, J Joseph, AS Desai, ME Farkouh, SM Hegde, AF Hernandez, A McGeer, HK Talbot, I Anand, DL Bhatt, CP Cannon, D DeMets, JM Gaziano, SG Goodman, K Nichol, MC Tattersall, JL Temte, J Wittes, C Yancy, B Claggett, Y Chen, L Mao, TC Havighurst, LS Cooper, SD Solomon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated